Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early versus later aspirin initiation in high-risk pregnancy
IRCT20240807062686N1Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Sep 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of aspirin in preeclampsia (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Blood pressure control, Pregnancy complications and 6 more. Started Sep 2024; status: completed.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on IRCT20240807062686N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240807062686N1.